Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,330
datasets available to search
ShareScore release 0.9.0
Dataset results
4,330 results for “Melanoma”
Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma
ClinicalTrials.gov study NCT00924001. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
ClinicalTrials.gov study NCT00001832. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations
ClinicalTrials.gov study NCT02296112. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors
ClinicalTrials.gov study NCT02573259. IPD Sharing: NO. Countries: 7. Publications: 3.
A Study of RO5185426 in Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT01248936. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma
ClinicalTrials.gov study NCT01838200. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma
ClinicalTrials.gov study NCT01153763. IPD Sharing: Not stated. Countries: 5. Publications: 4.
Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients
ClinicalTrials.gov study NCT00936221. IPD Sharing: Not stated. Countries: 12. Publications: 1.
Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma
ClinicalTrials.gov study NCT00896480. IPD Sharing: YES. Countries: 2. Publications: 1.
Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma
ClinicalTrials.gov study NCT03028948. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase II Safety Study of Vemurafenib Followed by Ipilimumab in Subjects With V600 BRAF Mutated Advanced Melanoma
ClinicalTrials.gov study NCT01673854. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma
ClinicalTrials.gov study NCT01721772. IPD Sharing: Not stated. Countries: 16. Publications: 6.
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
ClinicalTrials.gov study NCT03070392. IPD Sharing: Not stated. Countries: 14. Publications: 2.
An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma
ClinicalTrials.gov study NCT03068455. IPD Sharing: Not stated. Countries: 19. Publications: 3.
Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma
ClinicalTrials.gov study NCT02306850. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
ClinicalTrials.gov study NCT01143402. IPD Sharing: Not stated. Countries: 2. Publications: 3.
Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance
ClinicalTrials.gov study NCT01100528. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase IIB TL + YCWP + DC in Melanoma
ClinicalTrials.gov study NCT02301611. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes
ClinicalTrials.gov study NCT00509496. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT02111863. IPD Sharing: NO. Countries: 1. Publications: 3.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.